Access Statistics for Katharina Elisabeth Blankart

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany 0 0 1 13 2 7 15 46
A hard look at soft cost-control measures in healthcare organizations: Evidence from preferred drug policies in Germany 0 0 0 12 3 11 15 53
The Effects of Off-label Drug Use on Disability and Medical Expenditure 0 0 0 9 3 9 11 25
The effects of off-label drug use on disability and medical expenditure 0 0 0 2 1 7 8 17
Total Working Papers 0 0 1 36 9 34 49 141

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention 0 0 0 3 0 5 6 87
A systematic review of coverage decision-making on health technologies—Evidence from the real world 0 0 0 20 1 5 5 80
Analysing coverage decision-making: opening Pandora’s box? 0 0 0 3 1 2 3 38
Are patients more adherent to newer drugs? 0 0 0 1 1 2 5 29
Arzneimittel: Placebo bei Engpassbekämpfung 0 0 0 1 2 3 3 7
Dispensing behaviour of pharmacies in prescription drug markets 0 0 0 4 1 5 7 41
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark 0 0 0 1 1 1 3 37
Early Benefit Assessment of Pharmaceuticals in Germany 0 0 1 1 3 6 7 10
Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation 0 0 0 0 1 4 4 4
Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe 0 0 0 1 0 0 3 4
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia 1 1 1 11 1 4 5 57
Improving Service Provision - The Health Care Services' Perspective 0 0 0 0 2 13 17 28
Insurance barriers and inequalities in health care access: evidence from dual practice 0 0 0 1 2 8 15 23
Link between Process and Appraisal in Coverage Decisions 0 0 0 0 1 5 6 6
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany 0 0 0 0 0 1 3 3
Policy as a strategy to innovate in health care? A content analysis of innovation policies in Germany, 1994–2017 0 0 0 1 0 0 2 8
Regional Innovation Systems of Medical Technology: A knowledge production function of cardiovascular research and funding in Europe 0 0 1 2 0 4 10 16
The challenges of regulatory pluralism 0 0 0 0 1 5 9 10
The diffusion of generics after patent expiry in Germany 0 0 1 10 0 1 6 71
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany 0 0 0 5 2 5 8 43
The impact of physician-level drug budgets on prescribing behavior 0 0 0 5 0 3 7 32
To Seek Program Accreditation, Innovation, or Both?—Examining the Interdependencies in High-Reliability Health Care Organizations 0 0 0 2 1 4 6 11
Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis 0 0 0 5 0 1 5 45
Total Journal Articles 1 1 4 77 21 87 145 690

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-03-04